Denise Scots-Knight
2023
In 2023, Denise Scots-Knight earned a total compensation of $2.2M as Chief Executive Officer at Mereo BioPharma Group plc, a 1% decrease compared to previous year.
Compensation breakdown
| Bonus | $254,298 |
|---|---|
| Option Awards | $1,043,403 |
| Salary | $565,107 |
| Stock Awards | $285,358 |
| Other | $71,157 |
| Total | $2,219,323 |
Scots-Knight received $1M in option awards, accounting for 47% of the total pay in 2023.
Scots-Knight also received $254.3K in bonus, $565.1K in salary, $285.4K in stock awards and $71.2K in other compensation.
Rankings
In 2023, Denise Scots-Knight's compensation ranked 464th out of 2,983 executives tracked by ExecPay. In other words, Scots-Knight earned more than 84.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 464 out of 2,983 | 84th |
Division Manufacturing | 267 out of 1,637 | 84th |
Major group Chemicals And Allied Products | 182 out of 906 | 80th |
Industry group Drugs | 179 out of 869 | 79th |
Industry Pharmaceutical Preparations | 112 out of 627 | 82nd |
Source: SEC filing on April 24, 2024.
Scots-Knight's colleagues
We found two more compensation records of executives who worked with Denise Scots-Knight at Mereo BioPharma Group plc in 2023.